title: EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.
abstract: OBJECTIVE
  Knowledge of tumor mutational status has become a priority for effective NSCLC-tailored treatment. NSCLC diagnosis is more often reached through biopsy; thus, there is a clear need to implement for routine tumor molecular profiling on small cytological samples. This work aims to screen and compare the EGFR and KRAS mutational prevalence in fresh tumor cells and in corresponding routinely processed samples derived from trans-thoracic fine-needle aspiration. The latter currently represents the most appropriate diagnostic procedure in case of peripheral lesions, such as adenocarcinomas, which account for almost 40% of all NSCLCs and for the highest EGFR mutational rates.
  
  
  METHODS
  Two hundred and forty-four patients carrying peripheral lung masses underwent CT-guided aspiration. The obtained material was split, and a part was addressed to conventional histopathological analysis while the remaining one was stored at -20 °C. In case of confirmation of adenocarcinoma, tumor genomic DNA was extracted from both fresh and fixed material, and EGFR and KRAS sequencing was performed.
  
  
  RESULTS
  We identified 136 adenocarcinomas; from 134, we could recover enough material for the study. A full match was demonstrated between EGFR/KRAS mutational prevalences through the two approaches tested. We found EGFR mutations in 13 patients (9.7%); 7 were females and 11 never or former smokers. KRAS mutations occurred in 20 (14.9%) patients. EGFR and KRAS mutations were mutually exclusive.
  
  
  CONCLUSIONS
  Mutational screening on fresh cancer cells is an achievable, safe and cost-effective procedure which might allow routinely tumor molecular profiling as powerful integration of conventional histopathological analysis.
authors: Laboratory of Biochemistry and Genetics, Division of Pneumology, Department of Molecular Medicine, University and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
authors: Giulia M
authors: GM
authors: Stella
authors: Roberta
authors: R
authors: Scabini
authors: Simona
authors: S
authors: Inghilleri
authors: Francesca
authors: F
authors: Cemmi
authors: Simona
authors: S
authors: Corso
authors: Ernesto
authors: E
authors: Pozzi
authors: Patrizia
authors: P
authors: Morbini
authors: Adele
authors: A
authors: Valentini
authors: Roberto
authors: R
authors: Dore
authors: Simona
authors: S
authors: Ferrari
authors: Maurizio
authors: M
authors: Luisetti
authors: Michele
authors: M
authors: Zorzetto
mesh_terms: D000368:Aged; D001483:Base Sequence; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D004252:DNA Mutational Analysis / Q000379:methods*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D060888:Real-Time Polymerase Chain Reaction; D018631:ras Proteins / Q000235:genetics*
chemical_list: C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; C512478:EGFR protein, human; D066246:ErbB Receptors; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins
references: Virchows Arch. 2011 Jan;458(1):95-8
references: 21057810
references: Nat Rev Cancer. 2010 Nov;10(11):760-74
references: 20966921
references: Acta Radiol. 2008 Nov;49(9):991-4
references: 18651255
references: J Thorac Oncol. 2010 Oct;5(10):1706-13
references: 20871269
references: J Clin Oncol. 2003 Jun 15;21(12):2237-46
references: 12748244
references: N Engl J Med. 2005 Jul 14;353(2):172-87
references: 16014887
references: Clin Cancer Res. 2009 Jul 15;15(14):4554-60
references: 19584155
references: Sci Transl Med. 2011 Mar 23;3(75):75ra26
references: 21430269
references: Br J Cancer. 2008 Sep 16;99(6):923-9
references: 19238633
references: N Engl J Med. 2008 Sep 25;359(13):1367-80
references: 18815398
references: Science. 2003 May 9;300(5621):949
references: 12738854
references: Respir Med. 2012 Feb;106(2):173-83
references: 22104541
references: Nat Rev Cancer. 2007 Mar;7(3):169-81
references: 17318210
references: AJR Am J Roentgenol. 2010 Jan;194(1):266-9
references: 20028932
references: J Thorac Oncol. 2010 Oct;5(10):1664-7
references: 20871266